Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC-Reference-Cited by-同舟云学术

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

Published:2023-11 Issue:11 Volume:4 Page:100572
ISSN:2666-3643
Container-title:JTO Clinical and Research Reports
language:en
Short-container-title:JTO Clinical and Research Reports

Author:

Kim Hye Ryun,Awad Mark M.,Navarro Alejandro,Gottfried Maya,Peters Solange,Csőszi Tibor,Cheema Parneet K.,Rodriguez-Abreu Delvys,Wollner Mirjana,Yang James Chih-Hsin,Mazieres Julien,Orlandi Francisco J.,Luft Alexander,Gümüş Mahmut,Kato Terufumi,Kalemkerian Gregory P.,Luo Yiwen,Santorelli Melissa L.,Pietanza M. Catherine,Rudin Charles M.

Funder

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference10 articles.

1. Current standards for clinical management of small cell lung cancer;Farago;Transl Lung Cancer Res,2018

2. The humanistic burden of small cell lung cancer (SCLC): a systematic review of health-related quality of life (HRQoL) literature;Bennett;Front Pharmacol,2017

3. The state of the science in patient-reported outcomes for patients with lung cancer;Xiao;Semin Respir Crit Care Med,2020

4. Pembrolizumab or placebo plus etoposide and platinum as first-line therapy for extensive-stage small-cell lung cancer: randomized, double-blind, phase III KEYNOTE-604 study;Rudin;J Clin Oncol,2020

5. AJCC Cancer Staging Manual,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways;Experimental Hematology & Oncology;2024-04-23

2. A Visual Analysis of Patient-Reported Outcomes in Lung Cancer From 2013 to 2023;Cancer Control;2024-01